Legal & General Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-30
| Closed | -$9K | – | 3561 |
|
2021
Q1 | $9K | Hold |
30
| – | – | ﹤0.01% | 3402 |
|
2020
Q4 | $11K | Hold |
30
| – | – | ﹤0.01% | 3303 |
|
2020
Q3 | $9K | Sell |
30
-12
| -29% | -$3.6K | ﹤0.01% | 3264 |
|
2020
Q2 | $16K | Sell |
42
-13
| -24% | -$4.95K | ﹤0.01% | 3153 |
|
2020
Q1 | $13K | Sell |
55
-13
| -19% | -$3.07K | ﹤0.01% | 3079 |
|
2019
Q4 | $36K | Buy |
68
+7
| +11% | +$3.71K | ﹤0.01% | 2956 |
|
2019
Q3 | $27K | Hold |
61
| – | – | ﹤0.01% | 3016 |
|
2019
Q2 | $73K | Hold |
61
| – | – | ﹤0.01% | 2641 |
|
2019
Q1 | $76K | Buy |
61
+4
| +7% | +$4.98K | ﹤0.01% | 2573 |
|
2018
Q4 | $53K | Hold |
57
| – | – | ﹤0.01% | 2671 |
|
2018
Q3 | $82K | Hold |
57
| – | – | ﹤0.01% | 2566 |
|
2018
Q2 | $92K | Buy |
+57
| New | +$92K | ﹤0.01% | 2523 |
|
2017
Q2 | – | Sell |
-13
| Closed | -$7K | – | 3365 |
|
2017
Q1 | $7K | Hold |
13
| – | – | ﹤0.01% | 3222 |
|
2016
Q4 | $8K | Buy |
+13
| New | +$8K | ﹤0.01% | 3249 |
|